Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    thumbnail
    Making sense of the rapidly changing biosimilars landscape

    Strategies for adapting and achieving optimal market access

    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    Bioanalytical laboratory documentation
    Panel discussion: Flow cytometry in bioanalysis

    26 March 2026. Register today.

    thumbnail
    ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. News & Events
  3. Social media

Social media

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Showing 913 - 924 of 1038 results for "*"

Social media image
ICON Plc logo
ICON Plc

Meet the ICON Biotech team at #ESMO25, booth \#3034 to discover how our collaborative, agile, and science-driven team partners with biotech sponsors to navigate complexity and accelerate oncology clinical development—fro...

23 Sep
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Meet the ICON Biotech team at #ESMO25, booth #3034 to discover how our collaborative, agile, and science-driven team partners with biotech sponsors to navigate complexity and accelerate oncology clinical development—from...

23 Sep
1
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Innovation, collaboration, and insight come together at #SCDMUS, and ICON is excited to be part of it. From 27–30 September at the Baltimore Convention Center, our team will be on hand at booth 308 to connect and showcas...

23 Sep
2
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Innovation, collaboration, and insight come together at #SCDMUS, and ICON is excited to be part of it. From 27–30 September at the Baltimore Convention Center, our team will be on hand at booth 308 to connect and showcas...

23 Sep
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Explore our case study library to see how we help sponsors overcome obesity trial challenges with our industry-leading, flexible, end-to-end clinical development solutions. https://ow.ly/hecg50WY1be

22 Sep
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Explore our case study library to see how we help sponsors overcome obesity trial challenges with our industry-leading, flexible, end-to-end clinical development solutions. https://ow.ly/B3VY50WY1bi

22 Sep
3
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Why wait months when you can get results in weeks? Our real-time GMP manufacturing and clinical testing process accelerates decision-making, saving time and costs while improving early phase trial outcomes. Let’s get...

22 Sep
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Why wait months when you can get results in weeks? Our real-time GMP manufacturing and clinical testing process accelerates decision-making, saving time and costs while improving early phase trial outcomes. Let’s get...

22 Sep
1
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

In recognition of World Cancer Research Day which takes place on 24 September, we highlight the importance of oncology research and the efforts made to develop new, innovative therapies. However, on this day it's also im...

22 Sep
View post
View webpage
ICON Plc facebook post
ICON Plc logo
ICON Plc

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most sustain...

22 Sep
4
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most susta...

22 Sep
View post
View webpage
Social media image
ICON Plc logo
ICON Plc

ICON’s Victoria DeVeaugh-Geiss will participate in this panel hosted by Citeline, discussing how to embed risk-based strategies across clinical research. Don’t miss this opportunity to connect and learn. https://ow.ly/o9...

22 Sep
View post
View webpage
  • Previous
  • 1
  • …
  • 76
  • 77
  • 78
  • …
  • 87
  • Next
Filter by:

Filter by:

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence